Primary platinum resistance and its prognostic impact in patients with recurrent ovarian cancer: an analysis of three prospective trials from the NOGGO study group-Reference-Cited by-同舟云学术

Primary platinum resistance and its prognostic impact in patients with recurrent ovarian cancer: an analysis of three prospective trials from the NOGGO study group

Published:2021 Issue:3 Volume:32 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Trillsch Fabian¹^ORCID,Mahner Sven¹^ORCID,Czogalla Bastian¹^ORCID,Rottmann Miriam²^ORCID,Chekerov Radoslav³^ORCID,Braicu Elena Ioana³^ORCID,Oskay-Öczelik Gülten⁴^ORCID,Wimberger Pauline⁵^ORCID,Richter Rolf³^ORCID,Sehouli Jalid³^ORCID

Affiliation:

1. Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany.

2. Munich Cancer Registry, Bavarian Cancer Registry - Regional Centre Munich (LGL) at the University Hospital of Munich, Institute for Medical Information Processing, Biometry and Epidemiology, LMU Munich, Munich, Germany.

3. Charité Universitaetsmedizin Berlin, Department of Gynecology, Campus Virchow Klinikum, Berlin, Germany.

4. Praxisklinik Krebsheilkunde, Berlin, Germany.

5. Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Publisher

Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy

Subject

Obstetrics and Gynecology,Oncology,General Medicine

Link

https://ejgo.org/pdf/10.3802/jgo.2021.32.e37

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and molecular features of platinum resistance in ovarian cancer;Critical Reviews in Oncology/Hematology;2024-09

2. Efficacy and safety of an oral combination therapy of niraparib and etoposide in platinum resistant/refractory ovarian cancer: a single arm, prospective, phase II study;International Journal of Gynecologic Cancer;2024-07-29

3. SEfficacy and safety of apatinib in the treatment of patients with platinum‑resistant ovarian cancer: A systematic review and network meta‑analysis;Experimental and Therapeutic Medicine;2024-07-26

4. Angiogenesis inhibitors for the treatment of epithelial ovarian cancer;Cochrane Database of Systematic Reviews;2023-04-18

5. Mithplatins: Mithramycin SA‐Pt(II) Complex Conjugates for the Treatment of Platinum‐Resistant Ovarian Cancers;ChemMedChem;2022-11-22